Open AccessMedication-Free Research in Early Episode Schizophrenia: Why on Earth Would I Choose to Participate in Such Research?
Author(s) -
James K. McNulty
Publication year - 2006
Publication title -
schizophrenia bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.823
H-Index - 190
eISSN - 1745-1707
pISSN - 0586-7614
DOI - 10.1093/schbul/sbj057
Subject(s) - informed consent , harm , schizophrenia (object oriented programming) , categorical variable , psychology , psychiatry , schizophrenia research , psychotherapist , medicine , social psychology , alternative medicine , computer science , pathology , machine learning
The author concurs with Bola's conclusion that "a categorical prohibition of medication-free research in early episode schizophrenia on the ethical grounds of harm to human subjects should probably be reconsidered" on a case-by-case basis. The point that informed choice is rarely considered in the informed consent process is made. Several recommendations are made on how to augment the informed consent process and enhance the decision making of research participants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom